Stress signals activate the SAPK/JNK and p38 MAPK classes of protein kinases, which mediate cellular responses, including steps in apoptosis and the maturation of some cell types. We now show that stress signals initiated by transforming growth factor-␤1 (TGF-␤1) induce G 1 arrest through protein stabilization of the CDK inhibitor p21
Cell cycle progression is mediated by the sequential activation of members of the cyclin-dependent kinase (CDK) 1 family. Cell cycling is blocked when CDK-cyclin complexes cannot form or when the catalytic activity of these complexes is blocked through binding of a CDK inhibitor molecule. One of these inhibitors is p21
Cip1/Waf1 (1) , which was originally identified as a PCNA-binding protein (2) . p21 inhibits DNA replication by preventing PCNA from contributing to DNA polymerase ␦ and ⑀ function (3) . The p21 gene was also identified as a gene induced by the tumor suppressor p53 (4) and by cellular senescence (5). p21 is a major mediator of the G 1 growth arrest induced by activation of p53 in response to DNA damage (reviewed in Ref. 6 ). Additional critical roles of p21, as important as the p21 cell cycle inhibitory function, are its ability to stabilize the CDK4-cyclin D1 complex and to target CDK4 and cyclin D1 to the nucleus (7) . p21 promotes assembly of CDK4-cyclin D complexes and increases cyclin D1 accumulation by direct inhibition of GSK3␤-triggered nuclear export (8) . Thus, p21 is not simply a growth inhibitor.
Although most of the studies on p21 regulation have concentrated on its transcriptional regulation by p53-dependent and p53-independent mechanisms, a series of new studies have shown that p21 can be regulated by post-translational mechanisms. p21 is an unstable protein with a half-life of Ͻ30 min and is degraded by the proteasome in a ubiquitin-independent manner (9) . Ser 146 and Thr 145 are within both the PCNAbinding domain and the nuclear localization domain of p21. Phosphorylation of p21 at Ser 146 was shown to occur in vivo and to block p21/PCNA interaction (10) . Akt phosphorylates p21 at Thr 145 in Her-2/neu-transformed NIH3T3 cells (11) , at Thr 145 in nontransformed human endothelial cells (12) , and at both Thr 145 and Ser 146 in glioblastoma cells (13) . Akt also activates GSK3␤, which phosphorylates p21 at Thr 57 (14) . Phosphorylation at Ser 146 stabilizes p21 (13) , whereas phosphorylation at Thr 57 has been reported to destabilize p21 (14) . Phosphorylation at Thr 145 does not affect p21 stability, but results in the translocation of p21 from the nucleus to the cytoplasm in Her-2/neu-transformed NIH3T3 cells (11) . Phosphorylation of p21 at other sites within the PCNA-binding domain, the nuclear localization signal, the CDK-binding domain, or the cyclin-binding regions could be expected to modulate p21 activity and localization. In accordance with these expectations, it has been shown that mutation of the binding site for CDKs (W49R/F51S/D52A) increases p21 abundance by increasing its half-life, whereas mutation of the PCNA-binding site (M147A/D149A/F150A), which is also the proteasomal protein C8-binding domain (16) , decreases p21 levels by increasing its rate of turnover (15) . In this report, we demonstrate a novel function for the stress-activated protein kinases SAPK/JNK and p38 MAPK: the capacity to mediate increased protein stability of p21 by inducing phosphorylation at Ser 130 in vitro and in vivo.
EXPERIMENTAL PROCEDURES
Materials-TGF-␤1 was purchased from R&D Systems. Antibodies to p21 and to the FLAG epitope were from Transduction Laboratories and Sigma, respectively, and antibodies to the HA epitope and JNK1/2 were from Santa Cruz Biotechnology. Rabbit polyclonal antibodies to Akt, phospho-Akt, phospho-ERK1/2, ERK1/2, activated p38 MAPK, and p38 MAPK were from Cell Signaling and New England Biolabs Inc.
Purified recombinant GST-p38␣ and JNK1 were from Upstate Biotechnology, Inc. Polyvinylidene difluoride transfer paper (Immobilon-P) was purchased from Millipore Corp. All radioactive materials were purchased from PerkinElmer Life Sciences, and ECL reagents were from Amersham Biosciences. SB203580, LY294002, and PD98059 were purchased from Calbiochem, and LipofectAMINE was from Invitrogen. All other reagents were from Sigma.
Plasmids-pMT-5/p21
Cip1 -FLAG and its derivatives p21-T145A and p21-T145D were the kind gifts of Dr. M.-C. Hung. Wild-type p21
Cip1 was subcloned into pCMV-tag2 (Stratagene) for site-directed mutagenesis by the GeneEditor in vitro site-directed mutagenesis system (Promega). All mutant p21 constructs were sequenced to confirm the mutated sequence. FLAG-p38␣, FLAG-p38␤, FLAG-DN-p38␣, and FLAG-DNp38␤, all in pcDNA3, were the generous gifts of Dr. J. Han. pcDNA3-FLAG-DN-JNK1(apf) was from Dr. R. Davis; wild-type pSr␣3-HA 3 -JNK1 was from Dr. M. Karin; pSBE4-BV4/luc (where SBE is SMAD-binding element) and its control p6MBE-luc were from Dr. S. Kern; p21WWP-luc was from Dr. B. Vogelstein; SMAD4⌬C-FLAG was from Dr. R. Derynck; and p3TP-lux was from Dr. J. Massagué. p3TP-lux is composed of three TGF-␤ response elements and a fragment of the plasminogen activator inhibitor-1 promoter and can respond to SMADindependent signaling pathways activated by TGF-␤1.
Transient Transfections-For transient transfections, cells were plated in 12-well plates at an approximate density of 3 ϫ 10 5 and cultured for 24 h. LipofectAMINE (5 l/well) was mixed with a total of 720 ng of DNA for 30 min in serum-free medium and then added to the cells in serum-free medium for 16 -18 h with or without 6 ng/ml TGF-␤1, and luciferase activity was determined. Transfected DNA samples were composed of 200 ng of reporter construct, 20 ng of the pCMV-␤-galactosidase expression plasmid, and, depending on the experiment, 500 ng of test expression plasmid or vector control DNA. Cells were lysed, and both luciferase and ␤-galactosidase activities were measured using a TD-20/20 luminometer. Luciferase activity was normalized to ␤-galactosidase activity for differences in transfection efficiency. Each experiment was performed using triplicate data points and performed three to four times.
Cell Culture-The HD3 human colon carcinoma cell line used in this study was maintained in Dulbecco's modified Eagle's medium containing 7% fetal bovine serum, modified, and supplemented as described (17) . Cells were cultured in serum-free Dulbecco's modified Eagle's medium as described for TGF-␤1 treatment (18) .
Immunoprecipitations-Cells in 100-mm dishes were lysed in 0.7 ml of buffer containing 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 150 mM NaCl, 1% Nonidet P-40, 10% glycerol, 20 g/ml leupeptin, 20 g/ml aprotinin, 0.5 mM phenylmethylsulfonyl fluoride, 200 M sodium orthovanadate, and 20 mM sodium fluoride (lysis buffer). Lysates were pelleted in a microcentrifuge at 10,000 ϫ g for 20 min to remove insoluble material. JNK was isolated using anti-JNK antibody-agarose (10 l/mg of protein), which was incubated with the cell lysate at 4°C for 2 h and then washed five times with lysis buffer before analysis. p38 was isolated with anti-p38␣ antisera (1:50) by incubation at 4°C for 1 h, and immunoprecipitates were isolated by incubation with 10 l of protein G-agarose for 1 h and then washed five times with lysis buffer before analysis.
In Vitro Kinase Assay-The immunoprecipitates were washed five times with lysis buffer and three times with kinase buffer (50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 0.5 mM dithiothreitol, and 1 mM EGTA), incubated for 30 min at 30°C with 20 l of kinase buffer containing 10 M unlabeled ATP plus 2.5 Ci of [␥-
32 P]ATP and 1 g of purified recombinant p21 protein as substrate, and then analyzed by PAGE and autoradiography.
Immunodetection-Following treatment as indicated and washing with cold phosphate-buffered saline, cells were lysed as indicated (19) . Depending upon the experiment, 20 -50 g of the cell lysate was blotted onto polyvinylidene difluoride membranes after separation by SDS-PAGE. The blots were blocked in Tris-buffered saline (or in Tris-buffered saline containing 0.1% Tween 20) and 3-5% nonfat dry milk for 1 h and incubated for 1-2 h at room temperature with the primary antibody (1:500 dilution of antibodies to p21
Cip1 and tubulin; 2 g/ml anti-FLAG antibody; 0.5 g/ml anti-actin antibody; and 1:1000 dilution of antibodies to HA, GFP, Akt, phospho-Akt, ERK1/2, and phospho-ERK1/2), and proteins were subsequently detected by enhanced chemiluminescence.
Northern Analysis for p21 Cip1 -20 g of total RNA from each cell line was electrophoresed on a formaldehyde-containing 0.8% agarose gel and transferred to nylon membranes by downward capillary transfer. The membranes were hybridized to a full-length p21
Cip1 cDNA. Probes were labeled with 32 P by random priming. The blot was hybridized overnight at 68°C with at least 10 7 cpm of the labeled probe, washed three times for 7 min at room temperature with 1ϫ SSC and 1% SDS, washed for 20 min at 65°C with 0.1ϫ SSC and 0.1% SDS, and autoradiographed. The blots were stripped and rehybridized to GAPDH. Two-dimensional Phosphopeptide Analysis-Chymotrypsin cleavage and two-dimensional analysis of p21 phosphopeptides were carried out as described (20) . Following an in vitro kinase assay or immunoprecipitation of phospho-labeled proteins, the substrate was resolved by SDS-PAGE and transferred to a nitrocellulose membrane, and the protein band was identified by autoradiography and excised from the membrane. Proteins were digested with sequencing grade chymotrypsin (20 g in 200 l of freshly prepared 50 mM NH 4 HCO 3 overnight at 37°C), and the polypeptides were spotted onto 20 ϫ 20-cm thin-layer cellulose plates and separated in the first dimension by electrophoresis for 45 min at 1000 V on an HTLE-7002 electrophoresis system (C.B.S. Scientific Co., Inc.) using buffer containing 2.2% formic acid and 7.8% acetic acid at pH 1.9. Peptides were separated in the second dimension by chromatography for 9 h in phosphochromatography buffer (38% 1-butanol, 25% pyridine, and 7.5% acetic acid). Dried plates were exposed to Eastman Kodak Biomax MS film for 2-8 days. Ser(P) 130 was found in fragment 78 -150 (pI 7.03), and Thr(P) 57 was found in fragment 54 -63 (pI 3.24).
GST Fusion Proteins-p21 constructs were subcloned into the pGEX-4T1 vector (Amersham Biosciences) and expressed and purified as described (21) . Briefly, 300 ml of LB medium was seeded with 10% of an overnight culture of JM109 cells carrying the desired expression plasmid and incubated at 37°C for 1-2 h. Protein expression was induced with 0.1 mM isopropyl-␤-D-thiogalactopyranoside for 6 h at 24°C, and bacteria were collected by centrifugation and frozen at Ϫ70°C. Pellets (averaging 2 g each) were resuspended in 5 ml of ice-cold 10 mM Tris (pH 8.0), 150 mM NaCl, and 1 mM EDTA containing 100 g/ml lysozyme and protease inhibitors (Complete mini-tabs protease inhibitor mixture set, Roche Molecular Biochemicals) and incubated on ice for 15 min. Dithiothreitol was added to a final concentration of 5 mM, and Sarkosyl was added to a final concentration of 1.5% (w/v). Bacteria were lysed by sonication using a microtip (Misonix, setting 2.5) for 3 min with 5-s bursts separated by 5 s of rest. Lysates were clarified by centrifugation for 15 min at 15,000 ϫ g to remove insoluble material. 2% Triton X-100, 2.5 mM phenylmethylsulfonyl fluoride, and an additional 1ϫ protease inhibitor mixture were added to the clarified lysates, and 13-ml portions were incubated with 1 ml (bed volume) of glutathione-Sepharose 4B (Amersham Biosciences) at 4°C overnight with end-on rotation. Beads were washed six times with 10 volumes of ice-cold phosphatebuffered saline (140 mM NaCl, 2.7 mM KCl, 10 mM NaH 2 PO 4 , and 1.8 mM KH 2 PO 4 (pH 7.3)). GST fusion proteins used for in vitro kinase assays were eluted from the beads by overnight incubation at 4°C with 1 ml of glutathione elution buffer (75 mM HEPES (pH 7.4), 150 mM NaCl, 10 mM reduced glutathione, 5 mM dithiothreitol, and 0.1% Triton X-100) per ml of bead volume used. Recombinant p21 used in immune complex kinase reactions was cleaved from GST by incubation with thrombin (50 units/ml of bead volume in phosphate-buffered saline; Amersham Biosciences) for 18 h at room temperature. Thrombin was removed from the preparation by incubation with 1 ml of benzamidineSepharose 6B (Sigma) for 1 h at room temperature.
Band Analysis-Immunoblots were scanned using a Lacie Silverscanner DTP and a Power Macintosh 64, and densitometry was performed using the IP Lab Gel program (Scanalytics).
RESULTS

Post-transcriptional Up-regulation of p21 by TGF-␤1-Upregulation of protein levels of the CDK inhibitor p21
Cip1 is known to mediate the growth arrest of normal cells. The HD3 colon carcinoma line cell line has many characteristics of normal colonic epithelial cells and was cloned from its parental cell line because of its unusual "flat" morphology. At high density, the line spontaneously differentiates into one of the lineages in the normal colon, the fluid-transporting enterocyte. Differentiated cells exhibit a brush border and are joined by functional junctional complexes of tight junctions, gap junctions, and desmosomes (18) . HD3 cells exhibit some normal growth control, as they can be synchronized in G 1 by density arrest and are arrested in G 1 by TGF-␤1. Arrest occurs through inhibition of the kinases that phosphorylate the retinoblastoma protein (22) . TGF-␤1 increased p21 abundance up to 9-fold in HD3 cells as shown by Western blotting (Fig. 1A) . These elevated levels of p21 bind to and block CDK2 kinase activity as shown by im-munoprecipitation of CDK2 and kinase assay of histone H1 (23) . All these data are consistent with the known growtharresting properties of TGF-␤1.
The unexpected finding was that the TGF-␤1-induced increase in p21 protein levels in HD3 cells was mediated at the post-transcriptional level. Most studies have concentrated on transcriptional activation of p21. The increase in abundance of p21 in HD3 cells occurred rapidly and was detectable within 1-3 h ( Fig. 1B ; mean of two experiments). HD3 cells exhibit both mutant p53 (22) and the truncation mutation SMAD4Q311st (23), so transcription of p21 is p53-independent and should be independent of TGF-␤1-activated SMAD proteins. TGF-␤1 did not increase p21 mRNA levels in HD3 cells ( Fig. 1D ; mean of two experiments, p21 mRNA normalized to GAPDH mRNA) or activate a p21 promoter reporter (Fig. 1C ) in these cells. Taken together, these data confirm that the increase in p21 protein abundance by TGF-␤1 is mediated by post-transcriptional, SMAD-independent mechanisms.
TGF-␤1 Signaling Pathways in HD3 Cells-We next wished to determine which signaling pathways mediate the rapid posttranscriptional increase in p21 protein levels. TGF-␤1 can initiate both SMAD-dependent and SMAD-independent signaling pathways. Because HD3 cells exhibit the truncation mutation SMAD4Q311st (23) , TGF-␤1 signaling should be SMAD-independent. To resolve this issue, we cotransfected pSBE4-BV/luc, a reporter containing four repeats of an 8-bp palindromic SMAD-binding element that is known to be activated only by a SMAD3-SMAD4 complex (24) , into HD3 cells together with SMAD4 expression plasmids. The pSBE4-BV/luc reporter was activated only by TGF-␤1 when wild-type SMAD4 (but not DN-SMAD4⌬C) was cotransfected ( Fig. 2A) . Parallel experiments demonstrated that TGF-␤1 could not activate a mutant form of this reporter construct (p6MBE) when cotransfected with either wild-type or mutant SMAD4 (data not shown).
Therefore, endogenous SMAD4 is nonfunctional, and TGF-␤1 signaling is SMAD-independent in HD3 cells.
TGF-␤1 initiates several SMAD-independent signaling pathways, including Ras/ERK (25), Rho/JNK (26), TAK1/p38 MAPK (27, 28) , protein phosphatase 2A/p70 S6 kinase (29) , phosphatidylinositol 3-kinase/Akt (30), and possibly others. Because phosphorylation of p21 at Ser 146 has been reported to stabilize p21 (13), we concentrated on TGF-␤1-activated kinases that might phosphorylate p21 in vivo. p70 S6 kinase has been reported to be unable to phosphorylate p21
Cip1 (12) , so p70 S6 kinase was not studied.
TGF-␤1-activated kinase pathways that can be inhibited by chemical agents were examined initially. Activation of the 3TP-lux promoter reporter in HD3 cells by TGF-␤1 was challenged by treatment with the p38 MAPK inhibitor SB203580, the phosphatidylinositol 3-kinase inhibitor LY294002, or the MEK1 inhibitor PD98059. TGF-␤1 activation of 3TP-lux was blocked by SB203580, but not by LY294002 (Fig. 2B ), indicating that TGF-␤1 activates p38 MAPK, but not phosphatidylinositol 3-kinase and therefore not Akt in HD3 cells. PD98059 caused a strong activation of TGF-␤1 signaling in HD3 cells, implying that activated ERKs block TGF-␤1 signal transduction. Activated p38 is known to complex with ERK1/2 (31), so it is possible that blocking activation of ERKs leads to further up-regulation of p38 activity. These transient transfection data suggest that TGF-␤1 activates p38 (but not Akt, ERK1/2, or SMAD) signaling in HD3 cells. These data were confirmed by biochemical analysis. The increase in p21 abundance in HD3 cells was detectable within 1-3 h (Fig. 1B) , so any TGF-␤1 signaling that affects p21 must occur within this time frame.
TGF-␤1 activates p38 MAPK and JNK within 30 min, so both may play a role in p21 modulation. The activities of p38␣ and JNK1 were determined by immune complex kinase reaction using exogenous purified p21 protein cleaved from GST as abundance normalized to actin. HD3 cells that had been serum-starved overnight were treated with 0 -10 ng/ml TGF-␤1 in serum-free medium for 24 h. B, time course showing a rapid increase in p21 protein levels with TGF-␤1 (6 ng/ml) treatment. Shown is a plot of p21 abundance normalized to actin abundance. C, TGF-␤1 does not activate the p21WWP-luc promoter reporter in HD3 colon carcinoma cells. p21WWP-luc was transiently transfected and allowed to express for 16 h. One set of cultures was maintained in serum-free Dulbecco's modified Eagle's medium, whereas the other was treated with 6 ng/ml TGF-␤1 for an additional 24 h. Additional parallel HD3 cell cultures were not treated with TGF-␤1, but with 10 ng/ml 12-O-tetradecanoylphorbol-13-acetate (TPA) diluted in 0.2% Me 2 SO (DMSO) or with the Me 2 SO diluent alone. All experiments were performed four times with triplicate assay points. Luciferase values were normalized to 100% for controls (CT) Ϯ S.E. (bars). D, Northern blots for p21 Cip1 performed on parallel HD3 cell cultures treated with 6 ng/ml TGF-␤1 in serum-free Dulbecco's modified Eagle's medium or parallel cell cultures left untreated for periods up to 48 h. Blots were stripped and reprobed for GAPDH (G3PDH). The ratio of p21
Cip1 mRNA to GAPDH mRNA is plotted (means Ϯ S.E. of two experiments shown). substrate (Fig. 3A) . Cells were treated with 6 ng/ml TGF-␤1 for 0 -300 min, and p38␣ or JNK1 was immunoprecipitated at various times as indicated. TGF-␤1 activated both p38␣ and JNK1 by 15-30 min, and both kinases phosphorylated p21. The activity returned to background levels by 300 min. Controls include preimmune rabbit serum. Equal amounts of IgG were detected in the immunoprecipitates, and equal amounts of exogenous p21 were analyzed (Fig. 3A, lower panel) . GST had been cleaved from recombinant p21 before assay and migrated as a non-phosphorylated band at ϳ29 kDa (data not shown). A similar time course for p38 and JNK activation was seen when the kinase reaction was performed with activating transcription factor-2 (ATF2) as substrate (data not shown), which is a known in vivo substrate of the stress-activated MAPKs. In contrast, TGF-␤1 did not activate Akt or increase the low level activation of ERKs in HD3 cells within 30 min (Fig. 3B, left panel) or 60 min (right panel), confirming the transient transfection data. Treatment with epidermal growth factor or insulin-like growth factor was used as a positive control to activate ERKs and Akt. Therefore, the increase in p21 abundance does not occur through ERK or Akt activation.
TGF-␤1 Increases the Half-life of p21 by an SB203580-sensitive Mechanism-Because TGF-␤1 was shown to activate p38 in HD3 cells (Figs. 2 and 3 ), the effect of p38 inhibition on accumulation of the p21 protein was assayed. Treatment with the p38␣/␤ inhibitor SB203580 blocked the TGF-␤1-mediated increase in p21 abundance in a dose-dependent manner, with the amount of p21 halved by treatment with 5-10 M (Fig. 4A,  upper panel) . As a control for the specificity of the inhibitor, p21 mRNA levels were assayed by Northern analysis, and no modulation by SB203580 was seen (Fig. 4A, lower panel) , indicating that the effects on p21 are post-transcriptional and probably post-translational. The p21 protein is unstable, with a short half-life of ϳ20 -30 min in most cells. To determine whether the elevated levels of p21 in TGF-␤1-treated HD3 cells (Fig. 1) were due to protein stabilization, the turnover of the p21 protein was assayed. The half-life of p21 was determined by Western blotting after blocking translation with cycloheximide and was normalized to actin abundance determined on the same Western blot (Fig. 4 , C and E; means Ϯ S.E. of four separate experiments). The half-life of p21 was increased to ϳ90 -120 FIG. 3 . TGF-␤1 rapidly activates p38 and JNK (but not ERKs or Akt) in HD3 cells. A, parallel cultures were treated with 6 ng/ml TGF-␤1 for 0 -300 min; cells were lysed; and p38␣ or JNK was immunoprecipitated (IP) at the indicated times. The activities of p38 and JNK were assayed by in vitro complex kinase reactions with purified p21 protein cleaved from GST as the substrate. The upper panel is the autoradiogram, and the lower panel is Coomassie Blue staining of p21 in each reaction. Preimmune rabbit serum (Ct) was used as a control (C). Equal amounts of IgG were also detected in the immunoprecipitates (data not shown). B, shown are Western blots (WB) comparing activation of ERK and Akt in parallel cultures treated with 6 ng/ml TGF-␤1, 10 ng/ml epidermal growth factor (EGF), or 10 ng/ml insulinlike growth factor-I (IGF) for the indicated times. CT, control. min by TGF-␤1 treatment of HD3 cells, whereas SB203580 at 10 M blocked the TGF-␤1-mediated increase in the p21 half-life (Fig. 4, B-E) . At a slightly higher concentration than used here, SB203580 also inhibits the activity of JNK (32), so both p38 and JNK could play a role in stabilizing the p21 protein.
The same increase in half-life by TGF-␤1 and inhibition by SB203580 were seen when p21 levels were determined by immunoprecipitations during a cold chase following a 3-h pulse label with [ 35 S]methionine and [ 35 S]cysteine (Fig.  4, B and D) . Therefore, TGF-␤1 functions to increase p21 abundance by stabilizing the p21 protein through activation of p38 MAPK and possibly JNK. In contrast, treatment with the MEK1 inhibitor PD98059 did not block the TGF-␤1-mediated increase in the p21 half-life (data not shown), indicating that p38 (but not ERKs) modulate p21 stability in HD3 cells.
p38␣ and JNK1 Phosphorylate p21 in Vitro at Thr 57 and Ser 130 -There are two predicted phosphorylation sites for the MAPK superfamily in p21 that are conserved between human and rodent, Thr 57 -Pro and Ser 130 -Pro. Constructs were made by site-directed mutagenesis to mutate each site individually to alanine and to doubly mutate to T57A/S130A. An additional construct was made to mutate the Akt site of Ser 146 to alanine. An autoradiogram of an in vitro kinase assay of these GST-p21 constructs plus the Akt site mutant T145A is shown in Fig. 5A . Phosphorylation of GST-p21 constructs in vitro by purified recombinant JNK1 and by purified recombinant p38␣ was decreased by 75% by both the T57A mutation and the T57A/S130A double mutation, indicating that both kinases phosphorylate p21 predominately at Thr 57 in vitro. Mutation of Ser 130 to alanine reduced the phosphorylation by both kinases by ϳ20% in each of three experiments (Fig. 5B) . p21 constructs mutated at Ser 146 and Thr 145 (Akt sites) were still strongly phosphorylated by p38␣ and JNK1, indicating that neither kinase phosphorylates p21 at these sites. Mutation of the Thr 145 Akt site increased the sensitivity of the construct to phosphorylation by JNK, suggesting that phosphorylation at Thr 145 may inhibit JNK phosphorylation of p21. Neither p38␣ nor JNK1 phosphorylated GST (first lane in each blot). Autophosphorylated p38 was detected in each reaction by autoradiography (data not shown). Autophosphorylated JNK comigrated with the GST-p21 constructs, so it could not be distinguished. Coomassie Blue staining demonstrated that equivalent amounts of GST-p21 constructs were added to each reaction. Therefore, the SAPKs p38␣ and JNK1, which are activated by TGF-␤1 within the time frame necessary to stabilize the p21 protein against proteasomal degradation, both phosphorylate p21 in vitro at Thr 57 and Ser 130 .
p38␣ and JNK1 (but Not p38␤) Phosphorylate p21 in Vivo-
We next determined whether JNK1 or either isoform of p38 (␣ or ␤), which are inhibited by SB203580, phosphorylates p21 in vivo by coexpression experiments. Constructs for p38␣ and DN-p38␣ as a control were transfected into HD3 cells, allowed to express overnight, and then pulse-labeled with [ 32 P]orthophosphate in the presence of 10 g/ml anisomycin for 3 h to strongly activate exogenous p38␣. The 32 P-labeled p21 constructs and the p38 constructs were immunoprecipitated by their FLAG epitopes and analyzed by autoradiography after SDS-PAGE. The p21 protein coexpressed with wild-type p38␣ incorporated 3.5 times as much [ 32 P]orthophosphate as the p21 protein coexpressed with DN-p38␣ (Fig. 6A, upper panel) . Equivalent amounts of FLAG-p21 were immunoprecipitated as determined by Western blotting for the FLAG epitope (Fig. 6A,  lower panel) . Therefore, p21 is phosphorylated in vivo in a p38␣-sensitive manner. Both p38 constructs demonstrated similar expression as shown by examination of their abundance by Western blotting for their FLAG epitopes (Fig. 6A, lower  panel) . The wild-type p38␣ construct exhibited much more autophosphorylation than the DN-p38␣ construct, as expected. Therefore, p38␣ phosphorylates p21 in vivo. A similar experiment was performed with JNK1, DN-JNK, p38␤, and DN-p38␤ (Fig. 6B ). p38␤ and DN-p38␤ were expressed in vivo at similar levels, but the phosphorylation of p21 was not modulated by either form (Fig. 6B) , indicating that p38␤ does not phosphorylate p21 in vivo. However, DN-JNK1 reduced the phosphorylation of p21 by ϳ10-fold when protein expression levels were normalized. In addition, coexpression of JNK1 clearly increased the phosphorylation of p21 over control levels. Therefore, both JNK1 and p38␣ (but not p38␤) initiate the phosphorylation of p21 in vivo.
Coexpression of JNK1 Increases the Abundance of p21 in Vivo-Coexpression of DN-JNK inhibited p21 expression in a number of experiments in addition to Fig. 6B , so we turned to another experimental design. We assayed for the effect of JNK1 on p21 protein levels directly, hypothesizing that if JNK1 phos- phorylated p21 in vivo, p21 would be stabilized, and more protein would be detected. The effect of JNK1 on p21 protein levels in vivo was determined by transiently transfecting a FLAG epitope-tagged expression plasmid for p21 together with HA-tagged JNK1. An expression plasmid for GFP driven by the same promoter as that used in the p21 construct was used as an internal transcription rate control. Increasing amounts (1, 3, and 5 g) of wild-type JNK1 were transfected with the total amount of DNA kept constant using vector DNA. After 24 h of expression, the amounts of FLAG-p21 protein, GFP protein, and HA-JNK1 were determined by Western blotting. The efficiency of expression was similar in all cotransfections as shown by roughly similar levels of GFP protein (Fig. 6C) . However, increasing expression of JNK1 (as assayed by its HA tag) was correlated with increasing levels of p21. JNK1 at 3 and 5 g of DNA increased protein levels of cotransfected p21 by 3.7-and 6.1-fold over controls. Because transcriptional levels of GFP were similar in each experiment, expression of elevated levels of JNK1 caused a post-transcriptional dose-dependent increase in p21 abundance (Fig. 6C) . These data infer that the increase in p21 levels was mediated by increased protein stabilization through JNK-mediated phosphorylation of p21.
Mutant p21 Constructs Are Less Abundant in Vivo-Phosphorylation of p21 at Ser 146 by Akt has been reported to stabilize p21; and as a result, mutation of Ser 146 to a non-phosphorylated residue leads to the rapid proteolysis of p21 by the proteasome (13) . The steady-state levels of mutant p21 constructs were compared with wild-type p21 in the presence of cotransfected p38␣. The kinase was coexpressed to mediate phosphorylation of p21 at Ser 130 and Thr 57 . Each of the constructs had the same promoter, so it was expected that the major effects on p21 protein levels would be caused by differences in protein stability. The p21-S146A mutant was present at about half the level of wild-type p21 (Fig. 7A) , consistent with the known capability of S146A to destabilize p21 (13) . The p21-T57A/S130A double mutant was expressed at steady-state levels comparable to the unstable S146A construct, whereas the T57A and S130A mutant constructs were intermediate between the double mutant and wild-type p21 (Fig. 7A) . These data are consistent with the hypothesis that phosphorylation at Ser 130 and Thr 57 stabilizes p21, whereas mutation of these sites allows more rapid proteolysis. S130A or T57A Mutation Destabilizes p21-After transient transfection and expression of p21 constructs in HD3 cells, the half-life of each construct was determined by translational arrest by cycloheximide treatment (Fig. 7, B-F) . The abundance of p21 proteins was determined by Western blotting at intervals 0 -6 h after addition of cycloheximide. Cycloheximide is known to activate JNK (33, 34) , and our hypothesis is that JNK, as well as p38, phosphorylates and stabilizes p21. Supporting this hypothesis, the initial 30-min time point showed an increase in the protein level for the wild-type p21 and p21-S130A constructs, and the p21-T57A construct exhibited no loss in protein level (Fig. 7B) . However, the S130A, T57A, and double mutant constructs were more rapidly proteolyzed than the wild-type control (Fig. 7, B and D to a non-phosphorylatable alanine prevents a stabilizing phosphorylation. The effect of p38␣ on the stability of each p21 construct was next determined by cotransfection studies. Exogenous p38␣ was coexpressed at similar levels with each construct, and elevated levels were maintained at each time point (Fig. 7C) . Cotransfection of wild-type p21 with an expression construct for p38␣ caused a 2-5-fold increase in p21 protein levels, which FIG. 7 . Stability of mutant p21 constructs in vivo. A, HD3 cells were cotransfected with either wild-type (WT) or mutant FLAG-p21 constructs together with an expression construct for FLAG-p38␣. After 24 h, the p21 and p38 proteins were immunoprecipitated (IP) by their FLAG epitopes and Western blotted for FLAG. The two proteins were identified by their electrophoretic mobility. B, HD3 cells were cotransfected with either wild-type or mutant FLAG-p21 constructs together with an expression construct for FLAG-p38␣. After 24 h to allow expression of each construct, 20 g/ml cycloheximide (CH) was added to all cultures, and p21
Cip1 and ␤-tubulin abundance was determined at the indicated time points. C, the Western blot shows that equivalent amounts of exogenous p38␣ were expressed in each experiment shown in B. D-F, data from B and a duplicate experiment are plotted (means Ϯ S.E. (bars)).
was maintained during the cycloheximide treatment (Fig. 7, B and E). In contrast, coexpression of p38␣ together with the p21-T57A construct or the double mutant did not decrease their rapid proteolysis, which was clearly seen 1.5-3 h after addition of the drug (Fig. 7, B and E) . These data suggest that phosphorylation at Thr 57 is necessary for stabilization of p21. The p21-S130A mutant displays a different phenotype. Coexpression of p38␣ together with the p21-S130A construct decreased its rapid proteolysis (Fig. 7, B and F) . There is evidently a site (or sites) in p21-S130A that can be phosphorylated by p38␣ or another kinase activated by p38␣ and that stabilizes p21. Note that the stabilizing effect of p38␣ on p21-S130A was much less than its effect on wild-type p21. Phosphorylation at Ser 130 by either p38␣ or another kinase, perhaps JNK, is necessary to optimally stabilize p21.
TGF-␤1 and p38␣ Stabilize p21 in Vivo by Phosphorylation at Ser
130 -Although coexpressed p38␣ effectively stabilized p21 in vivo, it was necessary to define the sites of phosphorylation in vivo. Two-dimensional phosphopeptide mapping of p21 was performed. To facilitate the identification of the specific peptides, we initially performed mapping using wild-type and mutant p21 constructs phosphorylated in vitro by purified recombinant p38␣ using reaction mixtures containing [␥-
32 P]ATP. These p38␣-treated p21 constructs were digested to constituent peptides with chymotrypsin, and the 11 peptides were separated by electrophoresis, followed by thin-layer chromatography. As shown in Fig. 8A , peptide fragments including Thr 57 and Ser 130 were readily identified by comparison with mutant p21 constructs. The peptide containing Thr 57 migrated rapidly upon chromatography, but showed little electrophoretic mobility, whereas the peptide containing Ser 130 exhibited little migration upon chromatography, but efficient electrophoretic mobility (Fig. 8A) . HD3 cells were then transfected with wildtype FLAG-p21 alone or cotransfected with an expression plasmid for p38␣. After 24 h of expression, cells were switched to low phosphate medium; [ 32 P]orthophosphate was added; and cells were either treated for 6 h with 6 ng/ml TGF-␤1 or left untreated. Wild-type FLAG-p21 was then immunoprecipitated and digested with chymotrypsin, and peptide mapping was performed exactly as described above. Treatment with TGF-␤1 or coexpression with p38␣ yielded six 32 P-labeled peptides (Fig.  8B) , three of which were also seen in cells not treated with TGF-␤1. The remaining three peptides were identical in wildtype p21 isolated from TGF-␤1-treated cells and in wild-type p21 isolated from p38␣-expressing cells. In multiple experiments, both TGF-␤1 and p38␣ induced phosphorylation of the Ser 130 -containing peptide in vivo, but not the Thr 57 -containing peptide (Fig. 8B, upper panels, arrows) . TGF-␤1 treatment of cells transfected with p38␣ amplified the phosphorylation of the Ser 130 -containing peptide, confirming its designation as the site of in vivo phosphorylation.
The lack of phosphorylation at Thr 57 in vivo was surprising because this site was strongly phosphorylated in vitro (Fig. 5) . Two novel peptides were phosphorylated following TGF-␤1 treatment or p38␣ expression (Fig. 8B, arrowheads) . The hypothesis was considered that p21 is phosphorylated in vivo at a site atypical for MAPKs, Thr 55 , as well as at Thr 57 . This would add an additional phosphorylation site within peptide 54 -63 derived from p21 by chymotrypsin digestion. The doubly phosphorylated peptide would not have the same mobility as the Thr 57 -containing peptide derived following in vitro phosphorylation and could be one of the two novel peptides. To test this hypothesis, a FLAG-p21-T57A construct was expressed in HD3 cells, which were then treated with TGF-␤1 or left untreated as described above. The immunoprecipitated FLAG-p21-T57A construct was digested with chymotrypsin, and peptide mapping was performed exactly as described above. In duplicate experiments, TGF-␤1 treatment led to the phosphorylation of FIG. 8 . Peptide mapping of p21. A, in vitro phosphorylation of p21 constructs by purified recombinant p38␣. Wild-type (WT) p21, p21-T57A, p21-S130A, and p21-T57A/S130A were phosphorylated in vitro with p38␣; digested to completion with chymotrypsin; and then subjected to two-dimensional peptide mapping. The positions of the peptide containing Thr 57 and the peptide containing Ser 130 are indicated. B, in vivo phosphorylation of wild-type (WT) FLAG-p21 by 6 ng/ml TGF-␤1 treatment, by cotransfected p38␣, by both TGF-␤1 treatment and coexpression of p38␣, or by no treatment (Control) was determined by two-dimensional peptide mapping following digestion with chymotrypsin (autoradiograms shown in the upper panels). In vivo phosphorylation of mutant FLAG-p21-T57A by treatment with 6 ng/ml TGF-␤1 or by no treatment was determined by two-dimensional peptide mapping following digestion with chymotrypsin (autoradiograms shown in the lower panels). the Ser 130 -containing peptide and the same two novel peptides as had been seen in digests of wild-type p21 (Fig. 8B, lower  panels) . The same pattern of phosphorylated peptides was also seen when FLAG-p21-T57A was cotransfected with an expression plasmid for p38␣ (data not shown). Neither novel peptide could be sequenced because of their low abundance (data not shown). However, because the same novel phosphopeptides were detected in digests from wild-type p21 and the p21-T57A mutant, these peptides could not have been derived from p21 doubly phosphorylated at Thr 55 and Thr 57 in vivo. These data confirm the observation that Thr 57 is not phosphorylated in vivo in HD3 cells following treatment with TGF-␤1 or by activated p38. Possibly, phosphorylation of p21 at Ser 130 alters the conformation of p21, allowing phosphorylation by other kinases in vivo, or TGF-␤1-activated p38 in turn activates other downstream kinases that phosphorylate p21. There are several serines at the N and C termini of p21 that could be phosphorylated in vivo and give rise to the novel phosphopeptides. These data demonstrate that both TGF-␤1 and p38␣ induce phosphorylation of p21 at Ser 130 in vivo (Fig. 8) and that phosphorylation mediates p21 stabilization (Fig. 7) .
We then determined whether the stabilization of p21 mediated by TGF-␤1 in vivo (Figs. 1 and 4) could be prevented by mutation of p21 at Ser 130 . HD3 cells were cotransfected with either wild-type FLAG-p21 or FLAG-p21-S130A and, after 5 h of expression, treated with 6 ng/ml TGF-␤1 for 24 h. Cycloheximide was then added to block translation, and parallel lysates were examined for abundance of p21 and tubulin as a control for periods up to 6 h (Fig. 9) . TGF-␤1-treated p21 was more stable than untreated p21 at each point in the cycloheximide chase (Fig. 9, A and B) . Mutation of p21 to S130A (Fig. 9 , A and C) or to S130A/T57A (data not shown) prevented TGF-␤1 from stabilizing the mutant p21 construct. Taken together, these experiments demonstrate that p38␣ mediates the stabilization of the p21 protein in vivo by phosphorylation at Ser 130 .
DISCUSSION MAPK (ERK, SAPK/JNK, and p38) pathways are composed of three-tiered core signaling modules in which MAPKs are activated by concomitant phosphorylation on TXY in the activation loop of kinase subdomain VIII. MAPK phosphorylation and activation are catalyzed by MAPK kinases (MEKs or MKKs). MEKs in turn are activated by Ser/Thr phosphorylation catalyzed by a divergent family of MAPK kinase kinases. These in turn are regulated by a wide variety of upstream activators and inhibitors (reviewed in Ref. 34 ). TGF-␤1 has been shown to activate both SAPKs/JNKs and p38 proteins through SEK1, MKK3, and MKK6 (27) , and JNKs through activation of Rho (35) . The present study has implicated both p38␣ and SAPK/JNK1, activated by TGF-␤1, in cell cycle control through the stabilization of p21. The increased levels of p21 induced by TGF-␤1 in HD3 cells, the system used in this study, have been shown to mediate cell cycle arrest in G 1 through a block in retinoblastoma protein phosphorylation (22) . This is mediated by increased p21 binding to CDK2-cyclin E complexes, with a resultant inhibition of their kinase activity (23) . Using peptide mapping following in vivo phosphorylation, we have demonstrated that TGF-␤1-activated p38␣ mediates the stabilization of the p21 protein in vivo by phosphorylation at Ser 130 . We have also shown that the stabilization of p21 by TGF-␤1 in vivo is prevented by mutation of p21 Ser 130 to a non-phosphorylatable alanine. FIG. 9 . In vivo stability of p21 is abrogated by mutation to S130A. HD3 cells were transfected with either wild-type FLAG-p21 (p21 Wt) or FLAG-p21-S130A, treated for 24 h with or without 6 ng/ml TGF-␤1, and then treated with 20 g/ml cycloheximide for 1-6 h. A, parallel lysates were examined for the abundance of p21 and tubulin by Western blotting (WB). B, the effect of TGF-␤1 on wild-type p21 (p21WT) is shown from duplicate Western blots. C, the effect of TGF-␤1 on p21-S130A is shown from duplicate Western blots.
Both p38 and JNK are protein kinases that are activated by environmental stresses such as inflammatory cytokines, vasoactive peptides, heat shock, nutrient withdrawal, hypertonic stress, and genotoxic chemotherapy agents (reviewed in Ref. 34 ). These kinases function by transmitting stress signals to a bank of downstream transcription factors that alter cellular response. Responses to stress signals can include induction of apoptosis or cell differentiation. G 1 arrest has been detected in G 1 -synchronized NIH3T3 cells in response to p38, with greater arresting activity induced by the p38 upstream activator Cdc42Hs (36) . SAPK/JNK do not cause G 1 arrest, whereas expression of ERK induces a small increase in entry into S phase. Our observations in this study suggest that p38 mediates G 1 arrest through stabilizing p21 and delaying its proteasomal breakdown. G 1 arrest in response to stress signals would enable cells to repair stress-related damage. Alternatively, G 1 arrest in response to stress signals in some cells could be mediated by down-regulation of G 1 cyclins (37) . In the present study, coexpressed p38␣ and JNK1 (but not p38␤) increased the phosphorylation of p21 in vivo, and purified recombinant p38␣ and JNK1 phosphorylated p21 in vitro at Thr 57 and Ser 130 . In vivo stabilization of p21 was blocked by the p38␣/␤ inhibitor SB203580, providing strong corroboration for a role for p38␣ in p21 stabilization. The evidence for a role for JNK1 in p21 stabilization is less strong, and the lack of effect of SAPK/JNK in inducing G 1 arrest in NIH3T3 fibroblasts (36) argues against its involvement, at least in fibroblasts. However, both JNK and p38 are activated by TGF-␤1 in HD3 cells within the time frame necessary for phosphorylation of p21, and JNK1 phosphorylates p21 in vivo; so JNK may play a role in p21 stabilization and G 1 arrest in colon epithelial cells. Although the observations in this study that p21 is stabilized by p38␣ demonstrate a novel role for p38␣ in G 1 arrest, p38␣ has been shown to mediate rapid activation of the G 2 /M checkpoint after UV irradiation of dermal fibroblasts or HeLa cells (38) or after hypertonic stress in renal inner medullary epithelial cells (39) . Therefore, p38␣ functions to mediate checkpoints at both G 1 and G 2 /M.
The effect of phosphorylation of p21 at Thr 57 is controversial and may be cell type-specific. We have shown that mutation of this residue to alanine renders the mutant p21 construct less stable than wild-type p21 in HD3 colon epithelial cells (Fig. 7) . However, Rössig et al. (14) have presented clear evidence that GSK3␤ phosphorylates p21 at Thr 57 in vitro; that treatment of normal endothelial cells with LiCl, a GSK3␤ inhibitor, stabilizes p21; and that the p21-T57A mutant is more stable than wild-type p21 in endothelial cells. Although this difference in stability of p21-T57A was observed between HD3 colon carcinoma cells and endothelial cells, a second p21 mutation gave similar results in two cell types. Mutation of p21 at Ser 146 to alanine, which cannot be phosphorylated, destabilized p21 in glioblastoma cells (13) and also destabilized p21 in HD3 colon epithelial cells in the current study (Fig. 7 and data not shown) .
When confluent, the HD3 cells used in this study spontaneously differentiate to fluid-transporting enterocytes, which elaborate functional junctional complexes between adjacent cells that render them impermeable to transported fluids (18) . The transport of fluids from the apical through the basal side of this HD3 cell sheet causes a fluid bubble or "dome" to form in the differentiated monolayers. The normal colon is routinely exposed to hyperosmotic fluid (40), and this exposure immediately triggers a response to control cell volume through activation of p38 MAPK (41) . The mechanism of this control of cell volume has been delineated in Saccharomyces cerevisiae. Hyperosmotic conditions activate the p38 MAPK homolog Hog1, which stimulates accumulation of glycerol to increase intracellular osmolarity (42) . In mammalian cells, nutritional starvation, heat shock, and UV as well as osmotic shock activate p38 MAPK. The tumor suppressor protein p53 is also targeted by p38 by osmotic shock. p38 activates p53 transcriptional activity by phosphorylating p53 at Ser 33 (43) . Thus, p38 mediates responses to osmotic shock by phosphorylating the p53 tumor suppressor. The results of this study indicate that p38␣ can also respond to cellular stress by phosphorylating the p21 Cip1 cell cycle regulator, which also can be considered a tumor suppressor.
p38 MAPK has been shown to mediate differentiation in intestinal epithelium. Phosphorylated active forms of p38 were detected in the nuclei of differentiated villus cells (44) . Moreover, p38 levels increase when Caco-2/15 cells become confluent and differentiated, and p38-dependent phosphorylation of the homeoprotein transcription factor CDX3 occurs in differentiated Caco-2/15 cells (44) . Therefore, p38 MAPK modulates intestinal cell differentiation through regulation of CDX3 function. The stabilization of the p21 protein by p38 MAPK shown this study could initiate intestinal cell differentiation by arresting cells in G 1 as well as by enabling cells to arrest and repair in G 1 after environmental stresses.
